Masha V Poyurovsky

This inventor holds 12 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Kadmon Corporation, LLC, Kadmon Corportion, LLC. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masha V Poyurovsky. Retrieved from https://idiyas.com/inventor/masha-v-poyurovsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 12(Granted Patents)

Company Filing History:

11 out of 24

Kadmon Corporation, LLC

patents

1 out of 1

Kadmon Corportion, LLC

patent

Years Active: 2017-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12030857 - Glucose uptake inhibitors (2024-07-09),

2. 11926596 - Inhibitors of Rho associated coiled-coil containing protein kinase (2024-03-12),

3. 11613531 - Inhibitors of RHO associated coiled-coil containing protein kinase (2023-03-28),

4. 11479533 - Inhibitors of Rho associated coiled-coil containing protein kinase (2022-10-25),

5. 11071735 - Treatment of inflammatory conditions and autoimmune diseases with glucose uptake inhibitors (2021-07-27),

6. 10988484 - Glucose uptake inhibitors (2021-04-27),

7. 10729691 - Treatment of infectious diseases with glucose uptake inhibitors (2020-08-04),

8. 10696660 - Rho kinase inhibitors (2020-06-30),

9. 10273248 - Glucose uptake inhibitors (2019-04-30),

10. 10183931 - Rho kinase inhibitors (2019-01-22),

11. 10125144 - Rho kinase inhibitors (2018-11-13),

12. 9815820 - Rho kinase inhibitors (2017-11-14),

Title: Masha V Poyurovsky: Innovator in Medical Science

Introduction

Masha V Poyurovsky is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of medical science, particularly in the development of compounds that address critical health issues. With a total of 12 patents, her work is recognized for its potential impact on various diseases.

Latest Patents

Among her latest inventions is a series of glucose uptake inhibitors. This invention provides compounds that modulate glucose uptake activity and cellular transport of glucose, particularly targeting GLUTS3, as well as GLUT1-14 (SLC2A1-SLC2A14). These compounds are useful for treating diseases, including cancer, autoimmune diseases, inflammation, infectious diseases, and metabolic diseases. Another notable patent involves inhibitors of Rho associated coiled-coil containing protein kinase (ROCK). This invention relates to inhibitors of ROCK1 and/or ROCK2, providing methods for their inhibition that are useful for the treatment of various diseases.

Career Highlights

Masha has worked with notable companies such as Kadmon Corporation, LLC. Her innovative work has positioned her as a key figure in the medical research community, contributing to advancements that could change treatment protocols for several diseases.

Collaborations

Throughout her career, Masha has collaborated with esteemed colleagues, including Kevin G Liu and Ji-In Kim. These partnerships have fostered an environment of innovation and have led to the development of groundbreaking medical solutions.

Conclusion

Masha V Poyurovsky's contributions to medical science through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in the treatment of critical health issues.

Profile summary based on public USPTO records.